Information on adverse drug reactions-Proof of principle for a structured database that allows customization of drug information

被引:7
作者
Kusch, Marcel K. P. [1 ,2 ]
Zien, Alexander [3 ]
Hachenberg, Christian [3 ]
Haefeli, Walter E. [1 ,2 ]
Seidling, Hanna M. [1 ,2 ]
机构
[1] Heidelberg Univ, Dept Clin Pharmacol & Pharmacoepidemiol, Neuenheimer Feld 410, D-69120 Heidelberg, Germany
[2] Heidelberg Univ, Cooperat Unit Clin Pharm, Neuenheimer Feld 410, D-69120 Heidelberg, Germany
[3] Datapeut GmbH, Hans Bunte Str 8-10, D-69123 Heidelberg, Germany
关键词
Adverse drug reactions; Natural language processing; MedDRA; Summary of product characteristics; Structured drug information; Patient empowerment; PATIENTS WANT; MEDICATION;
D O I
10.1016/j.ijmedinf.2019.103970
中图分类号
TP [自动化技术、计算机技术];
学科分类号
0812 ;
摘要
Background: The drug information most commonly requested by patients is to learn more about potential adverse drug reactions (ADRs) of their drugs. Such information should be customizable to individual information needs. While approaches to automatically aggregate ADRs by text-mining processes and establishment of respective databases are well known, further efforts to map additional ADR information are sparse, yet crucial for customization. In a proof-of-principle (PoP) study, we developed a database format demonstrating that natural language processing can further structure ADR information in a way that facilitates customization. Methods: We developed the database in a 3-step process: (1) initial ADR extraction, (2) mapping of additional ADR information, and (3) review process. ADRs of 10 frequently prescribed active ingredients were initially extracted from their Summary of Product Characteristics (SmPC) by text-mining processes and mapped to Medical Dictionary for Regulatory Activities (MedDRA) terms. To further structure ADR information, we mapped 7 additional ADR characteristics (i.e. frequency, organ class, seriousness, lay perceptibility, onset, duration, and management strategies) to individual ADRs. In a PoP study, the process steps were assessed and tested. Initial ADR extraction was assessed by measuring precision, recall, and F-1-scores (i.e. harmonic mean of precision and recall). Mapping of additional ADR information was assessed considering pre-defined parameters (i.e. correctness, errors, and misses) regarding the mapped ADR characteristics. Results: Overall the SmPCs listed 393 ADRs with an average of 39.3 +/- 18.1 ADRs per SmPC. For initial ADR extraction precision was 97.9% and recall was 93.2% leading to an F-1-score of 95.5%. Regarding mapping of additional ADR information, the frequency information of 28.6 +/- 18.4 ADRs for each SmPC was correctly mapped (72.8%). Overall 77 ADRs (20.6%) of the correctly extracted ADRs did not have a concise frequency stated in the SmPC and were consequently mapped with 'frequency not known'. Mapping of remaining ADR characteristics did not result in noteworthy errors or misses. Conclusion: ADR information can be automatically extracted and mapped to corresponding MedDRA terms. Additionally, ADR information can be further structured considering additional ADR characteristics to facilitate customization to individual patient needs.
引用
收藏
页数:9
相关论文
共 24 条
[1]  
[Anonymous], 2010, COMM TERM CRIT ADV E
[2]   Patients' problems with new medication for chronic conditions [J].
Barber, N ;
Parsons, J ;
Clifford, S ;
Darracott, R ;
Horne, R .
QUALITY & SAFETY IN HEALTH CARE, 2004, 13 (03) :172-175
[3]   Patients' understanding of risk associated with medication use - Impact of European Commission guidelines and other risk scales [J].
Berry, DC ;
Raynor, DK ;
Knapp, P ;
Bersellini, E .
DRUG SAFETY, 2003, 26 (01) :1-11
[4]   Information needs about medication according to patients discharged from a general hospital [J].
Borgsteede, Sander D. ;
Karapinar-Carkit, Fatma ;
Hoffmann, Emmy ;
Zoer, Jan ;
van den Bemt, Patricia M. L. A. .
PATIENT EDUCATION AND COUNSELING, 2011, 83 (01) :22-28
[5]   A dataset of 200 structured product labels annotated for adverse drug reactions [J].
Demner-Fushman, Dina ;
Shooshan, Sonya E. ;
Rodriguez, Laritza ;
Aronson, Alan R. ;
Lang, Francois ;
Rogers, Willie ;
Roberts, Kirk ;
Tonning, Joseph .
SCIENTIFIC DATA, 2018, 5
[6]  
Duke Jon D, 2010, AMIA Annu Symp Proc, V2010, P177
[7]  
European Commission, 2009, APPLICANTS GUIDELINE
[8]  
European Medicines Agency, 2019, EUDRAVIGILANCE SYST
[9]  
European Medicines Agency, 2019, INCL EXCL CRIT IMP M
[10]   Patient information leaflets: informing or frightening? A focus group study exploring patients' emotional reactions and subsequent behavior towards package leaflets of commonly prescribed medications in family practices [J].
Herber, Oliver Rudolf ;
Gies, Verena ;
Schwappach, David ;
Thuermann, Petra ;
Wilm, Stefan .
BMC FAMILY PRACTICE, 2014, 15